首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1578155

CRISPR技術：全球市場

CRISPR Technology: Global Markets

出版日期: 2024年10月23日 | 出版商:

BCC Research | 英文 122 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球CRISPR技術市場規模預計將從2023年的34億美元和2024年的38億美元成長到2029年終的75億美元，在預測期內複合年成長率為14.4%。

從應用來看，藥物開發產業預計將從2024年的19億美元成長到2029年的38億美元，複合年成長率為15.5%。農業部門預計將從 2024 年的 10 億美元成長到 2029 年的 20 億美元，複合年成長率為 14.2%。

本報告調查了全球 CRISPR 技術市場，並提供了市場概況、市場影響因素和市場機會、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測以及各個細分市場和地區的分析。了詳細分析、競爭格局、主要企業概況等。

新興技術
CRISPR 的體內遞送
改進的Cas變體
AI
臨床試驗分析
臨床試驗分析（按研究類型）
臨床試驗分析（按狀態）
臨床試驗分析（按階段）
臨床試驗
專利分析
專利（按年份）
專利（按申請人）
專利（按主要所有者）
專利（按司法管轄區）
智慧財產權糾紛/專利問題

第5章市場區隔分析

細分細分
市場區隔：按應用
藥物開發
農業
診斷
其他
市場區隔：按最終用戶
生物技術和製藥公司
學術/政府研究院
CRO
地域分佈
市場區隔：按地區
北美洲
歐洲
亞太地區
其他領域

第6章競爭訊息

市場分析
戰略分析

第7章 CRISPR技術的永續性：ESG視角

ESG：簡介
CRISPR 技術的永續性：ESG 視角
ESG 關鍵議題
CRISPR技術的ESG效能分析
環境績效
社會表現
管治績效
BCC的結語

第8章附錄

調查方法
參考
簡稱
公司簡介
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

The global market for CRISPR technology in drug development application is expected to grow from $1.9 billion in 2024 to $3.8 billion by 2029, at a CAGR of 15.5% from 2024 to 2029.

The global market for CRISPR technology in agriculture application is expected to grow from $1.0 billion in 2024 to $2.0 billion by 2029, at a CAGR of 14.2% from 2024 to 2029.

Report Scope

This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.

Report Includes

32 data tables and 61 additional tables
An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
Discussion of the market potential for CRISPR technology
Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
A discussion on ESG challenges and ESG practices of the industry participants
A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Genome Editing
CRISPR
Introduction
Components of CRISPR
Mechanism of Action
CRISPR Gene Editing Workflow
Advantages and Disadvantages of CRISPR Technology
Pricing Analysis
PESTLE Analysis
Porter's Five Forces Analysis
Regulatory Landscape, by Type
Human
Gene Drives
Agriculture
Animals
Regulatory Landscape, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Rising Incidence of Chronic Diseases
Prevalence of Genetic Disorders
Government and Private Funding
Market Restraints
Alternative Technologies
Market Opportunities
Increase in the Number of Applications
Market Challenges
Complex and Evolving Regulatory Landscape
High Cost of CRISPR-based Therapy

Chapter 4 Emerging Technologies and Developments

Emerging Technologies
In Vivo Delivery of CRISPR
Improved Cas Variants
Artificial Intelligence
Clinical Trials Analysis
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Clinical Trials
Patent Analysis
Patents, by Year
Patents, by Top Applicant
Patents, by Top Owner
Patents, by Jurisdiction
Intellectual Property Disputes and Patent Issues

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown, by Application
Drug Development
Agriculture
Diagnostics
Other Applications
Market Breakdown, by End User
Biotech and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Market Analysis
Strategic Analysis

Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective

Introduction to ESG
Sustainability in CRISPR Technology: An ESG Perspective
Key ESG Issues
CRISPR Technology ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC

Chapter 8 Appendix

Methodology
References
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table : Global Market for CRISPR Technology, by Application, Through 2029
Table 1 : Comparison of Genome Editing Techniques
Table 2 : Comparison of sgRNA Formats
Table 3 : Comparison of Cas Enzymes
Table 4 : Pricing Analysis of CRISPR Technology Products, by Company
Table 5 : Regulatory Rating: Human Gene Editing, by Country/Region
Table 6 : Regulatory Rating: Gene Drives, by Country/Region
Table 7 : Regulatory Rating: Crops/Food, by Country/Region
Table 8 : Regulatory Rating: Animals, by Country/Region
Table 9 : Regulatory Landscape in Asia-Pacific Countries
Table 10 : Regulatory Landscape in South American Countries
Table 11 : Chronic Diseases: Applications of CRISPR-based Therapy
Table 12 : Genetic Disease: CRISPR-based Therapy
Table 13 : CRISPR Technology: Venture Funding, 2021-2024
Table 14 : Clinical Trials in CRISPR Technology, by Type of Study, August 2024
Table 15 : Clinical Trials in CRISPR Technology, by Status, August 2024
Table 16 : Clinical Trials in CRISPR Technology, by Phase, August 2024
Table 17 : Select Clinical Trials, 2024
Table 18 : Patents Granted on CRISPR Technology, by Top Applicant, 2020-2023
Table 19 : Patents Granted on CRISPR Technology, by Top Owner, 2020-2023
Table 20 : Patents Granted on CRISPR Technology, by Jurisdiction, 2020-2023
Table 21 : Global Market for CRISPR Technology, by Application, Through 2029
Table 22 : CRISPR-Based Genetic Therapy: Pipeline, 2024
Table 23 : Global Market for Drug Development in CRISPR Technology, by Region, Through 2029
Table 24 : CRISPR-Edited Crops
Table 25 : Global Market for Agriculture in CRISPR Technology, by Region, Through 2029
Table 26 : CRISPR-based Diagnostics
Table 27 : Global Market for Diagnostics in CRISPR Technology, by Region, Through 2029
Table 28 : Global Market for Other Applications in CRISPR Technology, by Region, Through 2029
Table 29 : Global Market for CRISPR Technology, by End User, Through 2029
Table 30 : Biotech and Pharmaceutical Partners of CRISPR Technology Companies
Table 31 : Recent Collaborations Among Biotech, Pharma and CRISPR Technology Firms, 2023-2024
Table 32 : Global Market for Biotech and Pharma Companies for CRISPR Technology, by Region, Through 2029
Table 33 : Global Market for Academics and Government Research Institutes for CRISPR Technology, by Region, Through 2029
Table 34 : Global Market for CRO for CRISPR Technology, by Region, Through 2029
Table 35 : Global Market for CRISPR Technology, by Region, Through 2029
Table 36 : North American Market for CRISPR Technology, by Country, Through 2029
Table 37 : European Market for CRISPR Technology, by Country, Through 2029
Table 38 : Asia-Pacific Market for CRISPR Technology, by Country, Through 2029
Table 39 : Leading Companies in the CRISPR Technology Market
Table 40 : Small and Medium-Sized Companies in the CRISPR Technology Market
Table 41 : Recent Developments in the CRISPR Technology Market, 2022-2024
Table 42 : Bioethical Issues and Risks Associated with CRISPR Technology
Table 43 : ESG Rankings for CRISPR Technology Companies, 2024*
Table 44 : ESG: Environmental Overview
Table 45 : ESG: Social Overview
Table 46 : ESG: Governance Overview
Table 47 : Information Sources in this Report
Table 48 : Abbreviations Used in this Report
Table 49 : Agilent Technologies Inc.: Company Snapshot
Table 50 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 51 : Agilent Technologies Inc.: Product Portfolio
Table 52 : Agilent Technologies Inc.: News/Key Developments, 2021
Table 53 : Beam Therapeutics: Company Snapshot
Table 54 : Beam Therapeutics: Financial Performance, FY 2022 and 2023
Table 55 : Beam Therapeutics: Product Portfolio
Table 56 : Beam Therapeutics: News/Key Developments, 2021-2023
Table 57 : Caribou Biosciences Inc.: Company Snapshot
Table 58 : Caribou Biosciences Inc.: Financial Performance, FY 2022 and 2023
Table 59 : Caribou Biosciences Inc.: Product Portfolio
Table 60 : Caribou Biosciences Inc.: News/Key Developments, 2021-2023
Table 61 : CRISPR Therapeutics: Company Snapshot
Table 62 : CRISPR Therapeutics: Financial Performance, FY 2022 and 2023
Table 63 : CRISPR Therapeutics: Product Portfolio
Table 64 : CRISPR Therapeutics: News/Key Developments, 2022-2024
Table 65 : Danaher Corp.: Company Snapshot
Table 66 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 67 : Danaher Corp.: Product Portfolio
Table 68 : Danaher Corp.: News/Key Developments, 2021-2024
Table 69 : Editas Medicine: Company Snapshot
Table 70 : Editas Medicine: Financial Performance, FY 2022 and 2023
Table 71 : Editas Medicine: Product Portfolio
Table 72 : Editas Medicine: News/Key Developments, 2022 and 2023
Table 73 : GenScript: Company Snapshot
Table 74 : GenScript: Financial Performance, FY 2022 and 2023
Table 75 : GenScript: Product Portfolio
Table 76 : GenScript: News/Key Developments, 2021
Table 77 : Intellia Therapeutics Inc.: Company Snapshot
Table 78 : Intellia Therapeutics Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Intellia Therapeutics Inc.: Product Portfolio
Table 80 : Intellia Therapeutics Inc.: News/Key Developments, 2021-2023
Table 81 : Lonza: Company Snapshot
Table 82 : Lonza Financial Performance, FY 2022 and 2023
Table 83 : Lonza: Product Portfolio
Table 84 : Lonza: News/Key Developments, 2022-2024
Table 85 : Merck KGaA: Company Snapshot
Table 86 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 87 : Merck KGaA: Product Portfolio
Table 88 : Merck KGaA: News/Key Developments, 2021
Table 89 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 90 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 91 : Thermo Fisher Scientific Inc: Product Portfolio
Table 92 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021 and 2022

List of Figures

Summary Figure : Global Market for CRISPR Technology, by Application, 2021-2029
Figure 1 : CRISPR: Mechanism of Action
Figure 2 : CRISPR Gene Editing: Workflow
Figure 3 : Advantages and Disadvantages of CRISPR Technology
Figure 4 : PESTLE Analysis - CRISPR Technology
Figure 5 : Market Dynamics of CRISPR Technology
Figure 6 : Estimated Numbers of All Cancer Cases, Both Sexes, 2022-2050
Figure 7 : Global Estimates: People with Diabetes (20 to 79), 2021-2045
Figure 8 : Emerging Trends/Technologies in the CRISPR Technology Market
Figure 9 : Patents Granted on CRISPR Technology, by Year, 2020-2022
Figure 10 : Global Market Shares for CRISPR Technology, by Application, 2023
Figure 11 : CRISPR Technology in Drug Development
Figure 12 : Uses of CRISPR in Agriculture
Figure 13 : Global Market Shares for CRISPR Technology, by End User, 2023
Figure 14 : Number of Scientific Publications on CRISPR, by Year, 2020-2023
Figure 15 : Global Market Shares for CRISPR Technology, by Region, 2023
Figure 16 : North American Market Shares of CRISPR Technology, by Country, 2023
Figure 17 : U.S. Market for CRISPR Technology, 2021-2029
Figure 18 : Canadian Market for CRISPR Technology, 2021-2029
Figure 19 : European Market Shares of CRISPR Technology, by Country, 2023
Figure 20 : German Market for CRISPR Technology, 2021-2029
Figure 21 : U.K. Market for CRISPR Technology, 2021-2029
Figure 22 : French Market for CRISPR Technology, 2021-2029
Figure 23 : Rest of the European Market for CRISPR Technology, 2021-2029
Figure 24 : Asia-Pacific Market Shares of CRISPR Technology, by Country, 2023
Figure 25 : Chinese Market for CRISPR Technology, 2021-2029
Figure 26 : Japanese Market for CRISPR Technology, 2021-2029
Figure 27 : Indian Market for CRISPR Technology, 2021-2029
Figure 28 : Rest of Asia-Pacific Market for CRISPR Technology, 2021-2029
Figure 29 : RoW Market for CRISPR Technology, 2021-2029
Figure 30 : Pillars of ESG
Figure 31 : Advantages of ESG for Companies
Figure 32 : Methodology Used in the CRISPR Technology Market
Figure 33 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 34 : Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
Figure 35 : Caribou Biosciences Inc.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Caribou Biosciences Inc.: Revenue Share, by Country/Region, FY 2023
Figure 37 : Danaher Corp.: Market Share, by Business Unit, FY 2023
Figure 38 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 39 : GenScript: Revenue Share, by Business Unit, FY 2023
Figure 40 : GenScript: Revenue Share, by Country/Region, FY 2023
Figure 41 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 42 : Lonza: Revenue Share, by Country/Region, FY 2023
Figure 43 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 44 : Merck KGaA: Revenue Share, by Region, FY 2023
Figure 45 : Thermo Fisher Scientific Inc.: Market Share, by Business Unit, FY 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023